Page 117 - 《中国药房》2023年16期

beta-glucan on human immune and cancer cells[J]. J He‐ therapy via oral route[J]. Theranostics，2020，10（19）：
matol Oncol，2009，2：25. 8479-8493.
[30] PARAYATH N N，NEHOFF H，MÜLLER P，et al. Sty‐ [40] PRADITYA D，KIRCHHOFF L，BRÜNING J，et al. Anti-
rene maleic acid micelles as a nanocarrier system for oral infective properties of the golden spice curcumin[J]. Front
anticancer drug delivery： dual uptake through enterocytes Microbiol，2019，10：912.
and M-cells[J]. Int J Nanomedicine，2015，10：4653-4667. [41] YOUNG S，RAI R，NITIN N. Bioaccessibility of cur‐
[31] HONG F，YAN J，BARAN J T，et al. Mechanism by cumin encapsulated in yeast cells and yeast cell wall par‐
which orally administered beta-1，3-glucans enhance the ticles[J]. Food Chem，2020，309：125700.
tumoricidal activity of antitumor monoclonal antibodies in [42] PLAVCOVÁ Z，ŠALAMÚNOVÁ P，SALOŇ I，et al. Cur‐
murine tumor models[J]. J Immunol，2004，173（2）： cumin encapsulation in yeast glucan particles promotes its
797-806. anti-inflammatory potential in vitro[J]. Int J Pharm，2019，
[32] SMET R D，DEMOOR T，VERSCHUERE S，et al. β-glu‐ 568：118532.
can microparticles are good candidates for mucosal anti‐ [43] ZHOU X，LING K J，LIU M Y，et al. Targeted delivery of
gen delivery in oral vaccination[J]. J Control Release， cisplatin-derived nanoprecursors via a biomimetic yeast
2013，172（3）：671-678. microcapsule for tumor therapy by the oral route[J]. Thera-
[33] LIU D Q，LU S，ZHANG L，et al. A biomimetic yeast nostics，2019，9（22）：6568-6586.
shell vaccine coated with layered double hydroxides in‐ [44] TENCEROVA M. Glucan-encapsulated siRNA particles
duces a robust humoral and cellular immune response （GeRPs）for specific gene silencing in Kupffer cells in
against tumors[J]. Nanoscale Adv，2020，2（8）：3494-3506. mouse liver[J]. Methods Mol Biol，2020，2164：65-73.
[34] LIU H，JIA Z H，YANG C M，et al. Aluminum hydroxide [45] REN T Y，GOU J X，SUN W X，et al. Entrapping of
colloid vaccine encapsulated in yeast shells with enhanced nanoparticles in yeast cell wall microparticles for
humoral and cellular immune responses[J]. Biomaterials， macrophage-targeted oral delivery of cabazitaxel[J]. Mol
2018，167：32-43. Pharm，2018，15（7）：2870-2882.
[35] SPECHT C A，LEE C K，HUANG H B，et al. Protection [46] LI X N，ZHAO Z M，YANG Y H，et al. Novel β-1，3-D-
against experimental cryptococcosis following vaccination glucan porous microcapsule enveloped folate-functionalized
with glucan particles containing Cryptococcus alkaline ex‐ liposomes as a Trojan horse for facilitated oral tumor-
tracts[J]. mBio，2015，6（6）：e01905-e01915. targeted co-delivery of chemotherapeutic drugs and quan‐
[36] SPECHT C A，LEE C K，HUANG H B，et al. Vaccination tum dots[J]. J Mater Chem B，2020，8（11）：2307-2320.
with recombinant Cryptococcus proteins in glucan par‐ [47] FATTAL-GERMAN M，BIZZINI B. Assessment of the
ticles protects mice against cryptococcosis in a manner de‐ anti-viral effect of a short-term oral treatment of mice
pendent upon mouse strain and cryptococcal species[J]. with live Saccharomyces cerevisiae cells[J]. Dev Biol
mBio，2017，8（6）：e01872-e01817. Stand，1992，77：115-120.
[37] HUANG H B，OSTROFF G R，LEE C K，et al. Characte- [48] BEIER R，GEBERT A. Kinetics of particle uptake in the
rization and optimization of the glucan particle-based vac‐ domes of Peyer’s patches[J]. Am J Physiol，1998，275
cine platform[J]. Clin Vaccine Immunol，2013，20（10）： （1）：G130-G137.
1585-1591. [49] WILLIAMS D L，MUELLER A，BROWDER W. Preclini‐
[38] CHE L，ZHOU J Z，LI S H，et al. Assembled nanomedi‐ cal and clinical evaluation of carbohydrate immunophar‐
cines as efficient and safe therapeutics for articular inflam‐ maceuticals in the prevention of sepsis and septic sequelae
mation[J]. Int J Pharm，2012，439（1/2）：307-316. [J]. J Endotoxin Res，1995，2（3）：203-208.
[39] ZHANG L，PENG H，ZHANG W，et al. Yeast cell wall （收稿日期：2023-04-18 修回日期：2023-07-26）
particle mediated nanotube-RNA delivery system loaded （编辑：孙 冰）
with miR365 antagomir for post-traumatic osteoarthritis

中国药房 2023年第34卷第16期 China Pharmacy 2023 Vol. 34 No. 16 · 2027 ·